UPM Institutional Repository

Evaluating the biological characteristics of targeted ZIF-8-encapsulated individual and combined drug systems for enhanced in vivo toxicity mitigation using folic acid ligands


Citation

Sadeq, Noor S. and Masarudin, Mas Jaffri and Abdul Rahman, Mohd Basyaruddin and Chia, Suet Lin and Ahmad, Syahida and Ahmad, Haslina (2026) Evaluating the biological characteristics of targeted ZIF-8-encapsulated individual and combined drug systems for enhanced in vivo toxicity mitigation using folic acid ligands. RSC Advances, 16 (2). pp. 1912-1931. ISSN 2046-2069

Abstract

The management of toxicity, and the fulfillment of safety requirements are considered as the most prominent challenges associated with cancer drug delivery. This study introduces a novel pH-responsive nanoparticle system based on ZIF-8 for the co-delivery of a ruthenium(ii) polypyridyl complex (RuPIP) and olaparib (Olap), which is designed for enhanced therapeutic efficacy and reduced systematic toxicity. To improve their biocompatibility and targeting, the nanoparticles were surface-coated with folic acid ligand, yielding the final RuPIP–Olap@ZIF-8-FA formulation. The RuPIP–Olap@ZIF-8 nanoparticles were fabricated through a rapid, eco-friendly method, and they achieved high co-loading capacities of 20.59% ± 1.38% for RuPIP and 10.77% ± 1.00% for Olap, as confirmed by HPLC analysis. In vitro, the FA-coated dual-drug system exhibited clear pH-responsive behaviour, releasing 80% of RuPIP and 99% of Olap at pH 5.0, compared with 32% and 29%, respectively, at pH 7.4 within 48 hours. The FA-coated RuPIP–Olap@ZIF-8 system also showed markedly enhanced cytotoxicity against the MCF-7 and MDA-MB-231 cell lines, reducing the cell viability to 11.38% and 13.48%, respectively. In comparison to the non-coated dual-drug system, the FA-coated dual-drug system did not induce lethality to 75% of embryos (LC50 > 250 µg mL−1) with significant improved survivability (90%) until 120 h of incubation. Results showed that RuPIP–Olap@ZIF8-FA did not cause significant malformations, even at elevated concentrations, and did not present aggregation issues toward healthy embryos. These findings establish RuPIP–Olap@ZIF-8-FA as a promising dual-drug nanocarrier capable of targeted delivery, pH-triggered release, and distinct therapeutic pathways. Its high loading efficiency, simplicity, and improved safety profile highlight its strong potential for advancement toward clinical translation.


Download File

[img] Text
122552.pdf - Published Version
Available under License Creative Commons Attribution.

Download (5MB)

Additional Metadata

Item Type: Article
Subject: Chemistry (all)
Subject: Chemical Engineering (all)
Divisions: Faculty of Biotechnology and Biomolecular Sciences
Faculty of Science
Institute of Bioscience
Institute of Nanoscience and Nanotechnology
DOI Number: https://doi.org/10.1039/d5ra07756g
Publisher: Royal Society of Chemistry
Keywords: ZIF-8 nanoparticles; Folic acid functionalization; Drug co-delivery; Ruthenium(II) polypyridyl complex (RuPIP); Olaparib (Olap); pH-responsive release; Cancer therapy; Toxicity mitigation; In vivo safety; Nanocarrier design
Depositing User: Ms. Che Wa Zakaria
Date Deposited: 22 Jan 2026 07:00
Last Modified: 22 Jan 2026 07:00
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1039/d5ra07756g
URI: http://psasir.upm.edu.my/id/eprint/122552
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item